David Suran | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Best Researcher Award

David Suran — Maribor University Medical Centre

David Suran
Affiliation Maribor University Medical Centre
Country Slovenia
Scopus ID 26650243300
Documents 310
Citations 332
h-index 11
Subject Area Cardiovascular Pharmacology
Event International Top Pharmaceutical Awards
ORCID 0000-0002-4073-9286

David Suran is a Slovenian clinician-scientist associated with Maribor University Medical Centre whose academic contributions focus on cardiovascular pharmacology, myocardial infarction research, renal complications in cardiovascular disease, and clinical cardiology. His published works demonstrate interdisciplinary engagement in cardiology, nephrology, internal medicine, and evidence-based cardiovascular outcomes research. Through extensive clinical investigations and collaborative medical publications, Suran has contributed to the understanding of myocardial infarction management, acute kidney injury, atrial fibrillation, cardiovascular risk assessment, and translational clinical medicine.[1]

Abstract

This academic article presents a structured overview of the research profile and scholarly contributions of David Suran in the fields of cardiovascular medicine and cardiovascular pharmacology. The article summarizes publication trends, citation indicators, collaborative clinical investigations, and thematic areas of research related to myocardial infarction, atrial fibrillation, acute kidney injury, cardiovascular outcomes, and evidence-based medicine. It further evaluates the suitability of the researcher for recognition under the Best Researcher Award category associated with the International Top Pharmaceutical Awards. The analysis reflects the researcher’s sustained participation in peer-reviewed scientific communication and clinically oriented medical investigations.[2]

Keywords

Cardiovascular Pharmacology, Myocardial Infarction, Acute Kidney Injury, Clinical Cardiology, Cardiovascular Outcomes, Internal Medicine, Atrial Fibrillation, Evidence-Based Medicine, Translational Medicine, Cardiovascular Research

Introduction

Cardiovascular diseases remain among the leading causes of global morbidity and mortality, thereby necessitating continuous scientific advancements in prevention, diagnosis, and therapeutic intervention. Clinical cardiology research plays a significant role in improving patient outcomes through observational studies, pharmacological assessments, and evidence-driven treatment approaches. David Suran has contributed to this research landscape through publications addressing cardiovascular complications, myocardial infarction management, renal impairment in cardiovascular conditions, and clinical predictors associated with adverse cardiovascular outcomes.[3]

His academic and clinical work demonstrates integration between hospital-based medical practice and scholarly research activities. Publications indexed through Scopus and ORCID indicate active participation in collaborative research initiatives involving cardiovascular medicine, nephrology, metabolic disorders, and public health-related cardiovascular investigations.[4]

Research Profile

David Suran is affiliated with Maribor University Medical Centre in Slovenia and serves in academic and clinical capacities associated with cardiology and cardiovascular medicine. ORCID records indicate involvement in internal medicine specialization, cardiovascular medicine specialization, and biomedical technology research training.[5]

The researcher’s Scopus profile records 310 documents, 332 citations, and an h-index of 11, reflecting sustained scholarly activity in cardiovascular medicine and related interdisciplinary areas. His research portfolio demonstrates thematic continuity in myocardial infarction studies, atrial fibrillation management, renal dysfunction following cardiovascular intervention, and prognostic cardiovascular biomarkers.[1]

  • Clinical specialization in cardiology and cardiovascular medicine
  • Research emphasis on myocardial infarction and cardiovascular complications
  • Peer-reviewed contributions to nephrology and cardiovascular outcomes research
  • Participation in collaborative translational medicine studies
  • Integration of evidence-based medicine within clinical cardiology practice

Research Contributions

A significant portion of Suran’s research has focused on cardiovascular risk assessment and patient outcomes in myocardial infarction populations. Publications investigating lipoprotein(a), acute kidney injury, obesity-related cardiovascular complications, and atrial fibrillation recurrence contribute to contemporary cardiovascular clinical understanding.[6]

Several studies have explored relationships between cardiovascular biomarkers and patient prognosis in acute myocardial infarction. Research addressing anemia, renal deterioration after percutaneous coronary intervention, and inflammatory or metabolic risk factors illustrates the clinical relevance of his investigations in routine medical practice.[3]

Additional investigations involving machine learning applications in medicine and explainable artificial intelligence demonstrate interdisciplinary engagement beyond traditional cardiovascular pharmacology. These contributions indicate evolving participation in digital health analytics and data-driven clinical methodologies.[3]

Publications

David Suran’s publications focus on cardiovascular pharmacology, myocardial infarction outcomes, atrial fibrillation, and renal complications associated with cardiovascular disease. His research includes clinical studies on lipoprotein(a), acute kidney injury, cardiovascular risk prediction, and interventional cardiology methodologies. Several works also examine evidence-based therapeutic approaches and translational medical applications in cardiovascular medicine.[4]

Research Impact

The scholarly contributions of David Suran demonstrate measurable academic engagement through peer-reviewed publications, interdisciplinary collaboration, and citation visibility in cardiovascular medicine. His work contributes to ongoing clinical discussions concerning myocardial infarction prognosis, cardiovascular complications, and evidence-based therapeutic approaches.[3]

Research outputs indexed in Scopus and ORCID further indicate continuity of scientific productivity and participation in internationally accessible medical literature databases. Studies involving cardiovascular risk biomarkers, renal complications, and outcome-based analyses hold practical significance for clinical cardiology and cardiovascular pharmacology research communities.[4]

Award Suitability

The Best Researcher Award recognizes individuals demonstrating sustained academic productivity, research quality, interdisciplinary collaboration, and meaningful scholarly contributions within their respective domains. David Suran’s publication profile, clinical research involvement, and documented scientific outputs indicate alignment with the evaluative expectations associated with international academic recognition programs.[4]

His research contributions to cardiovascular pharmacology and clinical cardiology demonstrate consistency in peer-reviewed dissemination, evidence-oriented investigation, and participation in clinically relevant scientific studies. The integration of cardiovascular outcomes research with practical clinical observations further strengthens the academic significance of his work within pharmaceutical and medical research communities.[4]

Conclusion

David Suran has established a research profile centered on cardiovascular medicine, myocardial infarction outcomes, and translational clinical investigations. His scholarly work reflects contributions to evidence-based cardiovascular research, interdisciplinary medical collaboration, and clinically applicable scientific inquiry. Through publications indexed in internationally recognized databases, Suran continues to contribute to the advancement of cardiovascular pharmacology and related medical sciences. The cumulative body of work supports his recognition within professional academic award frameworks focused on research excellence and clinical impact.[4]

References

  1. Elsevier. (n.d.). Scopus author details: David Suran, Author ID 26650243300. Scopus.https://www.scopus.com/authid/detail.uri?authorId=26650243300
  2. ORCID. (n.d.). David Suran ORCID profile and publication summary.https://orcid.org/0000-0002-4073-9286
  3. Suran, D. et al. (2024). Lipoprotein(a) as a Risk Factor for Recurrent Acute Myocardial Infarction and Mortality. Diagnostics.https://doi.org/10.3390/diagnostics14232757
  4. Suran, D. et al. (2023). Obesity and Acute Kidney Injury in Patients with ST-Elevation Myocardial Infarction. Journal of Clinical Medicine.https://doi.org/10.3390/jcm12237311
  5. ORCID. (n.d.). Professional activities and academic qualifications of David Suran.https://orcid.org/0000-0002-4073-9286
  6. Suran, D. et al. (2022). Lipoprotein(a) in Cardiovascular Diseases: Insight From a Bibliometric Study. Frontiers in Public Health.https://doi.org/10.3389/fpubh.2022.923797
  7. Suran, D. et al. (2019). Impact of KDIGO-Defined Acute Kidney Injury on Mortality after Percutaneous Coronary Intervention. Cardiorenal Medicine.https://doi.org/10.1159/000492287

Chrysoula Boutari | Cardiovascular Pharmacology | Research Excellence Award

Published on by Top Pharmaceutical

Assist. Prof. Dr. Chrysoula Boutari | Cardiovascular Pharmacology | Research Excellence Award

Aristotle University of Thessaloniki | Greece

Assist. Prof. Dr. Chrysoula Boutari is an Assistant Professor and Registrar of Internal Medicine at Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, specializing in metabolic and cardiovascular disorders. She holds a medical degree with specialization in Internal Medicine and advanced research training through a fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School, where she contributed to clinical and experimental medicine initiatives. Her professional experience includes leadership in multiple research and consultancy projects, with a strong focus on metabolic syndrome, obesity, MASLD, and dyslipidemias. She has produced a significant body of scholarly work with a high citation impact and h-index, alongside contributions to academic literature including books on cardiovascular iatrogenicity. She serves as Associate Editor and Guest Editor for reputable international journals, reflecting her influence in scientific publishing. Her professional affiliations include prominent atherosclerosis societies, highlighting her engagement with the global research community and continued commitment to advancing metabolic health research.

Citation Metrics (Google Scholar)

2735
2000
1000
500
0

2735

72

24

Citations

Documents

h-index


Top 5 Featured Publications

 

Rafita Haque | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Rafita Haque | Cardiovascular Pharmacology | Best Researcher Award

PhD Student at Florida International University | United States

Ms. Rafita Haque is a dedicated PhD candidate in Computer and Electrical Engineering at Florida International University, USA. With a strong academic and research background in AI, biomedical sensors, and data security, she is passionate about advancing digital health solutions. Her teaching and research experiences span universities in Bangladesh and the U.S., with significant industry exposure in software quality assurance. She has authored several indexed publications, received international awards, and holds active research interests in cardiovascular health monitoring using signal analysis and intelligent systems. Ms. Haque’s career is a blend of academic excellence, innovative research, and practical engineering application.

Publication Profile 

Google Scholar

Orcid

Education 

Ms. Haque is pursuing a PhD in Computer and Electrical Engineering at Florida International University, Miami, with a research focus on AI, biomedical devices, and cardiovascular health management. She holds a Master’s degree in Software Engineering from Daffodil International University, where her thesis explored C2C information quality in Facebook-based purchase decisions. She completed her B.Sc. in Computer Science and Engineering from Gono Bishwabidyalay, focusing on network security systems. Her academic training reflects a strong foundation in data analysis, security, and AI-driven healthcare technologies, supported by hands-on research and multiple technical certifications in networking and development.

Experience 

Ms. Rafita Haque has rich academic and industry experience. She served as a lecturer in Software Engineering at Daffodil International University and in Computer Science at the Asian University of Bangladesh, teaching core computing and system design courses. She also worked as an SQA Engineer at Data-Soft Systems and Cloud Production Ltd., where she tested and improved AML solutions for the banking and insurance sectors. Her work involved ASP.NET, MySQL, Python, and NoSQL. She’s recognized for developing secure network systems and cloud-based tools, blending teaching excellence with real-world software and systems engineering experience.

Awards  

Ms. Rafita Haque has earned multiple academic and professional honors. She received the Best Paper Award (IoT Track) at the 1st International Conference on Technology Innovation and Data Sciences (ICTIDS) in Malaysia, 2019. She also won the Best Project Award at Gono Bishwabidyalay’s Project Fair (2015) for her secure network system. Additionally, she presented her research at the Blockchain Olympiad Bangladesh (BCOLBD) in 2020. Her outstanding academic track and publication record in Scopus and Springer-indexed journals, alongside her active participation in international conferences, underscore her contributions to technology, cybersecurity, and healthcare innovation.

Research Focus 

Ms. Haque’s research interests include Artificial Intelligence (AI), Biomedical Sensors, Photoplethysmogram (PPG) signal analysis, data security, and cardiovascular health management systems. Her work integrates machine learning with optical and biomedical systems to create intelligent diagnostic tools. She is particularly focused on AI-based monitoring of cardiovascular conditions, secured health data exchange using blockchain, and real-time signal analysis. Her multidisciplinary expertise bridges computer science with healthcare innovation, emphasizing secure, smart systems that support precision medicine. Through cutting-edge publications and collaborative research, she aims to advance smart biomedical technologies and secure healthcare data infrastructures globally.

Publication Top Notes

Broken authentication and session management vulnerability: a case study of web application
Journal: International Journal of Simulation Systems, Science & Technology
Cited by: 48
Year: 2018

Blockchain-based information security of electronic medical records (EMR) in a healthcare communication system
Cited by: 36
Year: 2021

Integration of blockchain and remote database access protocol-based database
Cited by: 14
Year: 2020

Modeling the role of C2C information quality on purchase decision in Facebook
Cited by: 13
Year: 2018

A cloud of things (CoT) approach for monitoring product purchase and price hike
Cited by: 10
Year: 2021

Identification of construction era for Indian subcontinent ancient and heritage buildings by using deep learning
Cited by: 10
Year: 2020

Performance Analysis of Different Feature Detection Techniques for Modern and Old Buildings
Cited by: 9
Year: 2018

A study of Ajax template injection in web applications
Cited by: 9
Year: 2018

A Combined Model of Blockchain, Price Intelligence and IoT for Reducing the Corruption and Poverty
Cited by: 8
Year: 2018

Digital Certificate Forgery Prevention Using Blockchain Technology
Year: 2023

Deep long short-term memory (LSTM) network for continuous blood pressure monitoring
Year: 2025
Cited by: 1

An Ensemble-Based AI Approach for Continuous Blood Pressure Estimation in Health Monitoring Applications
Journal: Sensors
Year: 2025

Conclusion

Ms. Rafita Haque is a promising early-career researcher with significant accomplishments in AI, biomedical applications, and information security. Her interdisciplinary focus, hands-on industry experience, academic excellence, and publication record collectively position her as a strong candidate for the Research for Best Researcher Award. With further engagement in high-impact, independently led projects and global research forums, she is poised to emerge as a future leader in her field.